Temple University Lewis Katz School of Medicine is a clinical research site located in Philadelphia, Pennsylvania, United States 19140.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Temple University Lewis Katz School of Medicine has participated in 5 clinical trials with 1 currently active.
Therapeutic areas: Uterine Cervical Neoplasms, Amyotrophic Lateral Sclerosis, ALS.
Sponsors: Fox Chase Cancer Center, Tanabe Pharma America, Inc., SK Life Science, Inc..
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Temple University Lewis Katz School of Medicine has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Temple University Lewis Katz School of Medicine has 5 clinical trials on record, with 1 currently active. Their work covers Uterine Cervical Neoplasms, Amyotrophic Lateral Sclerosis, ALS.
Yes — Temple University Lewis Katz School of Medicine holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.